REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centalab Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Centalab Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Centalab Company Limited is based in Thailand. The head office is in Pathum Thani. The company operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 29, 1978. 200 (2024) employees currently work for Centalab Company Limited. From the latest financial highlights, Centalab Company Limited reported a net sales revenue increase of 18.31% in 2024. Its’ total assets recorded a growth of 18.76%. The net profit margin of Centalab Company Limited increased by 8.32% in 2024.

Headquarters
7/3 Moo 1 Phahon Yothin Road
Pathum Thani; Central Thailand; Postal Code: 12120

Contact Details: Purchase the Centalab Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Centalab Company Limited report to view the information.
Financial Auditors:
Purchase the Centalab Company Limited report to view the information.
Incorporation Date:
May 29, 1978
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Centalab Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
18.31%▲
Total Operating Revenue
17.57%▲
Operating Profit
144.32%▲
EBITDA
144.32%▲
Net Profit/Loss for the Period
146.93%▲
Total Assets
18.76%▲
Total Equity
13.86%▲
Operating Profit Margin
10.32%▲
Net Profit Margin
8.32%▲
Return on Equity (ROE)
6.56%▲
Quick Ratio
-2.08%▼
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo